$HALB Patented LDN+ Drug hits an enormous milestone as it enters a significant Safety Trial Protocol under a CRADA contract for Military Active Duty and Veterans. https://www.accesswire.com/849919/halberds-patented-drug-ldn-the-subject-of-a-limited-clinical-trial-under-an-innovative-four-company-cooperative-research-and-development-crada-contract